Compound: Foretinib

Drug Target: MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.